|601 Congress Street , Boston, MA 02210-2805|
|Fund Manager||Nathan Thooft|
|Manager Tenure||8 Years 4 Months|
To seek high total return until the fund's target retirement date, with a greater focus on income as the target date approaches. Total return, commonly understood as the combination of income and capital appreciation, includes interest, capital gains, dividends, and distributions realized over a given period of time. Under normal market conditions, the fund primarily invests its assets in underlying funds using an asset allocation strategy designed for investors expected to retire around the year 2045. The portfolio managers of the fund allocate assets among the underlying funds according to an asset allocation strategy that becomes increasingly conservative over time. John Hancock Retirement Choices at 2045 Portfolio, which is designed for investors planning to retire around the year 2045, has a target asset allocation of 82% of its assets in underlying funds that invest primarily in equity securities. The fund will have greater exposure to underlying funds that invest primarily in equity securities than will a John Hancock Retirement Choices Portfolio with a closer target date. Over time, the asset allocation strategy will change according to a predetermined glide path shown in the following chart. As the glide path shows, the fund's asset mix becomes more conservative as time elapses. This reflects the desire to reduce investment risk and volatility as retirement approaches.
|Asset Type||% Of Allocation|
|Total Net Assets||810.72 M|
|Criteria||3 Years||5 Years||10 Years|
|Minimum Initial IRA||$0|
|Timeframe||Average Annual Current Performance Monthly As Of 08/31/2021||Average Annual Current Performance Quarterly As Of 06/30/2021||Avg Annual Current Performance Monthly As Of 08/31/2021||Avg Annual Current Performance Quarterly As Of 06/30/2021|
|Life Of Fund||
|Symbol||Company Name||% Of Assets|
|BND||VANGUARD TOT BOND MKT IDX ETF||7.48%|
|0P0000VD||J HANCOCK 2 STRATEGIC EQ ALLO||68.57%|
|VO||VANGUARD MID CAP ETF||5.24%|
|HYLB||XTRACKERS USD HI YLD CORP BD||2.32%|
|VCIT||VANGUARD INTERM TRM CORP BD E||1.72%|
|VWOB||VANGUARD EM MKT GOVT BD ETF||1.43%|
|VWO||VANGUARD FTSE EMER MARKET ETF||1.35%|
|VHT||VANGUARD HEALTH CARE ETF||1.11%|
|XLF||FINANCIAL SELECT SECTOR SPDR||1.10%|
|VGT||VANGUARD INFO TECH ETF||1.06%|
Join the Action Alerts PLUS Community today!
AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.
Twitter's payment would settle a shareholder lawsuit that the company misled investors about its user engagement totals.
Pharmacy giant CVS plans to add 25,000 ahead of flu season and coronavirus-related vaccinations.
Stocks could drop 20% as fiscal stimulus is withdrawn and economic growth slows, a Morgan Stanley strategist says.
Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.
Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.
DR Horton said "significant disruptions in the supply chain ... along with tightness in the labor market" will lead to a modestly lower full-year sales forecast.
Colgate-Palmolive stock was upgraded to buy with an $86 price target at Deutsche Bank.
Jim Cramer discusses the market selloff, Evergrande, debt ceiling talks, the upcoming Federal Reserve meeting, Pfizer and more in his latest video interview with TheStreet.
Wynn Resorts faces regulatory uncertainty in Macau, but Morgan Stanley says the casino operator is still 'worth the risk.'